Home/Filings/4/0001517737-25-000057
4//SEC Filing

MAHONEY RICHARD S. 4

Accession 0001517737-25-000057

CIK 0000883241other

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 2:14 PM ET

Size

15.6 KB

Accession

0001517737-25-000057

Insider Transaction Report

Form 4
Period: 2025-06-18
MAHONEY RICHARD S.
Chief Revenue Officer
Transactions
  • Sale

    Common Stock

    2025-06-18$471.27/sh2,949$1,389,7831,485 total
  • Sale

    Common Stock

    2025-06-18$471.18/sh1,192$561,6421,485 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-181,1924,173 total
    Exercise: $354.45From: 2024-02-17Exp: 2030-02-17Common Stock (1,192 underlying)
  • Sale

    Common Stock

    2025-06-18$471.19/sh4,869$2,294,2201,485 total
  • Exercise/Conversion

    Common Stock

    2025-06-18$319.20/sh+2,949$941,3214,434 total
  • Exercise/Conversion

    Common Stock

    2025-06-18$354.45/sh+1,192$422,5042,677 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-06-182,9495,898 total
    Exercise: $319.20From: 2023-05-31Exp: 2029-05-31Common Stock (2,949 underlying)
Footnotes (4)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2024.
  • [F2]Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.07 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F3]Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $469.14 to $473.33. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F4]1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Issuer

SYNOPSYS INC

CIK 0000883241

Entity typeother

Related Parties

1
  • filerCIK 0001693085

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 2:14 PM ET
Size
15.6 KB